ArticleOxidative medicine and cellular longevity2020

WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling.

Xiaoyu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.